PROF. ANTHONY EUGENE ORO, M.D.,PH.D.
Dermatology at Blake Wilbur Dr, Palo Alto, CA
License number
California G79854
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
900 Blake Wilbur Dr ROOM W0001, Palo Alto, CA 94304
Phone
(650) 723-6316
(650) 723-7177 (Fax)
(650) 723-7177 (Fax)
Professional information
Anthony Eugene Oro, Stanford CA
Specialties:
Dermatologist
Address:
269 Campus Dr, Stanford, CA 94305
900 Blake Wilbur Dr, Palo Alto, CA 94304
900 Blake Wilbur Dr, Palo Alto, CA 94304
Education:
Doctor of Medicine
Board certifications:
American Board of Dermatology Certification in Dermatology
Anthony Eugene Oro, Stanford CA
Specialties:
Dermatology, Internal Medicine
Work:
Stanford University
900 Blake Wilbur Dr, Stanford, CA 94305
900 Blake Wilbur Dr, Stanford, CA 94305
Education:
University of California at San Diego (1993)
Dr. Anthony E Oro, Redwood City CA - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Stanford Hospital and Clinics DER
450 Broadway St, Redwood City 94063
(650) 723-6316 (Phone)
450 Broadway St, Redwood City 94063
(650) 723-6316 (Phone)
Certifications:
Dermatology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Stanford Hospital and Clinics DER
450 Broadway St, Redwood City 94063
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
450 Broadway St, Redwood City 94063
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of California, San Diego, School Of Medicine
Graduated: 1993
Stanford University Hospital
University Of California, San Diego, School Of Medicine
Graduated: 1993
Stanford University Hospital
Inhibitors Of Atypical Protein Kinase C And Their Use In Treating Hedgehog Pathway-Dependent Cancers
US Patent:
2012028, Nov 8, 2012
Filed:
Mar 16, 2012
Appl. No.:
13/422936
Inventors:
Scott X. Atwood - Stanford CA, US
Anthony Oro - Stanford CA, US
Anthony Oro - Stanford CA, US
International Classification:
A61K 38/10, A61P 35/00, C12N 15/113, C07K 7/08, C12N 5/09, C07D 403/12, A61K 31/4355, C07D 491/107, A61K 31/45, C07D 211/40, A61K 31/713, A61K 31/496
US Classification:
514 195, 514 193, 514 44 A, 536 245, 530327, 51425405, 544371, 514278, 546 15, 514328, 546219, 435375
Abstract:
Methods and compositions are provided for modulating Hedgehog (Hh) pathway signaling in a cell. Aspects of the methods include methods for inhibiting Hh pathway-promoted cancer proliferation and/or metastasis that is promoted by Hh pathway signaling, methods for treating cancers promoted by Hh pathway signaling, and methods for screening candidate agents for the ability to treat a cancer promoted by Hh pathway signaling. In addition, reagents and kits thereof that find use in practicing the subject methods are provided.
Bone Morphogenetic Protein Antagonist And Uses Thereof
US Patent:
2009004, Feb 12, 2009
Filed:
Mar 13, 2008
Appl. No.:
12/075944
Inventors:
Hanson Zhen - Stanford CA, US
Julie Sneddon - Palo Alto CA, US
Patrick O. Brown - Stanford CA, US
Anthony Oro - Stanford CA, US
Julie Sneddon - Palo Alto CA, US
Patrick O. Brown - Stanford CA, US
Anthony Oro - Stanford CA, US
International Classification:
A61K 39/395, C12Q 1/68, A61P 35/00, A61K 31/711, A61K 31/7105, G01N 33/53
US Classification:
4241301, 435 6, 435 71, 514 44
Abstract:
The present invention relates to the use of proteins that are differentially expressed in tumor associated stromal cells, as compared to normal stromal, as biomolecular targets for tumor treatment therapies. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention.